North America Prostate Cancer Diagnostics Market by Manufacturers, Countries, Type and Application, Forecast to 2022

April 2017 | 119 pages | ID: N63290BC47CEN
GlobalInfoResearch

Abstracts

The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.
Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.

SCOPE OF THE REPORT:

This report focuses on the Prostate Cancer Diagnostics in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers

• Genomic Health
• Abbott
• OPKO
• Siemens Healthcare
• DiaSorin
• bioMeriux
• Roche
• MDx Health
• Beckman Coulter
• Myriad Genetics
• Ambry Genetics

Market Segment by Countries, covering

• United States
• Canada
• Mexico

Market Segment by Type, covers

• Tumor Biomarker Tests
• Imaging
• Biopsy
• Other

Market Segment by Applications, can be divided into

• < 55
• 55-75
• > 75

There are 15 Chapters to deeply display the North America Prostate Cancer Diagnostics market.

Chapter 1, to describe Prostate Cancer Diagnostics Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Prostate Cancer Diagnostics, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Prostate Cancer Diagnostics, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Prostate Cancer Diagnostics market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Prostate Cancer Diagnostics Research Findings and Conclusion, Appendix, methodology and data source

Contents

1 MARKET OVERVIEW

1.1 Prostate Cancer Diagnostics Introduction
1.2 Market Analysis by Type
  1.2.1 Tumor Biomarker Tests
  1.2.2 Imaging
  1.2.3 Biopsy
  1.2.4 Other
1.3 Market Analysis by Applications
  1.3.1 %
  1.3.2 55-75
  1.3.3
1.4 Market Analysis by Countries
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 Mexico Status and Prospect (2012-2022)
  1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Genomic Health
  2.1.1 Profile
  2.1.2 Prostate Cancer Diagnostics Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Genomic Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 Genomic Health News
2.2 Abbott
  2.2.1 Profile
  2.2.2 Prostate Cancer Diagnostics Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Abbott Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 Abbott News
2.3 OPKO
  2.3.1 Profile
  2.3.2 Prostate Cancer Diagnostics Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 OPKO Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 OPKO News
2.4 Siemens Healthcare
  2.4.1 Profile
  2.4.2 Prostate Cancer Diagnostics Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Siemens Healthcare Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 Siemens Healthcare News
2.5 DiaSorin
  2.5.1 Profile
  2.5.2 Prostate Cancer Diagnostics Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 DiaSorin Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.5.4 Business Overview
  2.5.5 DiaSorin News
2.6 bioMeriux
  2.6.1 Profile
  2.6.2 Prostate Cancer Diagnostics Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 bioMeriux Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.6.4 Business Overview
  2.6.5 bioMeriux News
2.7 Roche
  2.7.1 Profile
  2.7.2 Prostate Cancer Diagnostics Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Roche Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.7.4 Business Overview
  2.7.5 Roche News
2.8 MDx Health
  2.8.1 Profile
  2.8.2 Prostate Cancer Diagnostics Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 MDx Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.8.4 Business Overview
  2.8.5 MDx Health News
2.9 Beckman Coulter
  2.9.1 Profile
  2.9.2 Prostate Cancer Diagnostics Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 Beckman Coulter Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.9.4 Business Overview
  2.9.5 Beckman Coulter News
2.10 Myriad Genetics
  2.10.1 Profile
  2.10.2 Prostate Cancer Diagnostics Type and Applications
    2.10.2.1 Type
    2.10.2.2 Type
  2.10.3 Myriad Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.10.4 Business Overview
  2.10.5 Myriad Genetics News
2.11 Ambry Genetics
  2.11.1 Profile
  2.11.2 Prostate Cancer Diagnostics Type and Applications
    2.11.2.1 Type
    2.11.2.2 Type
  2.11.3 Ambry Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.11.4 Business Overview
  2.11.5 Ambry Genetics News

3 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET COMPETITION, BY MANUFACTURER

3.1 North America Prostate Cancer Diagnostics Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Prostate Cancer Diagnostics Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Prostate Cancer Diagnostics Manufacturer Market Share
  3.4.2 Top 5 Prostate Cancer Diagnostics Manufacturer Market Share
3.5 Market Competition Trend

4 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET ANALYSIS BY COUNTRIES

4.1 North America Prostate Cancer Diagnostics Sales Market Share by Countries
4.2 North America Prostate Cancer Diagnostics Sales by Countries (2012-2017)
4.3 North America Prostate Cancer Diagnostics Revenue (Value) by Countries (2012-2017)

5 NORTH AMERICA MARKET SEGMENTATION PROSTATE CANCER DIAGNOSTICS BY TYPE

5.1 North America Prostate Cancer Diagnostics Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 North America Prostate Cancer Diagnostics Sales and Market Share by Type (2012-2017)
  5.1.2 North America Prostate Cancer Diagnostics Revenue and Market Share by Type (2012-2017)
5.2 Tumor Biomarker Tests Sales Growth and Price
  5.2.1 North America Tumor Biomarker Tests Sales Growth (2012-2017)
  5.2.2 North America Tumor Biomarker Tests Price (2012-2017)
5.3 Imaging Sales Growth and Price
  5.3.1 North America Imaging Sales Growth (2012-2017)
  5.3.2 North America Imaging Price (2012-2017)
5.4 Biopsy Sales Growth and Price
  5.4.1 North America Biopsy Sales Growth (2012-2017)
  5.4.2 North America Biopsy Price (2012-2017)
5.5 Other Sales Growth and Price
  5.5.1 North America Other Sales Growth (2012-2017)
  5.5.2 North America Other Price (2012-2017)

6 NORTH AMERICA MARKET SEGMENTATION PROSTATE CANCER DIAGNOSTICS BY APPLICATION

6.1 North America Prostate Cancer Diagnostics Sales Market Share by Application (2012-2017)
6.2 % 55 Sales Growth (2012-2017)
6.3 55-75 Sales Growth (2012-2017)
6.4 75 Sales Growth (2012-2017)

7 UNITED STATES PROSTATE CANCER DIAGNOSTICS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 United States Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Prostate Cancer Diagnostics Sales and Market Share by Type
7.3 United States Prostate Cancer Diagnostics Sales by Application (2012-2017)
7.4 United States Prostate Cancer Diagnostics Sales, Revenue and Market Share by Manufacturer
  7.4.1 United States Prostate Cancer Diagnostics Sales and Market Share by Manufacturer
  7.4.2 United States Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer
7.5 United States Prostate Cancer Diagnostics Export and Import (2012-2017)

8 CANADA PROSTATE CANCER DIAGNOSTICS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 Canada Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Prostate Cancer Diagnostics Sales and Market Share by Type
8.3 Canada Prostate Cancer Diagnostics Sales by Application (2012-2017)
8.4 Canada Prostate Cancer Diagnostics Sales, Revenue and Market Share by Manufacturer
  8.4.1 Canada Prostate Cancer Diagnostics Sales and Market Share by Manufacturer
  8.4.2 Canada Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer
8.5 Canada Prostate Cancer Diagnostics Export and Import (2012-2017)

9 MEXICO PROSTATE CANCER DIAGNOSTICS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Mexico Prostate Cancer Diagnostics Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Prostate Cancer Diagnostics Sales and Market Share by Type
9.3 Mexico Prostate Cancer Diagnostics Sales by Application (2012-2017)
9.4 Mexico Prostate Cancer Diagnostics Sales, Revenue and Market Share by Manufacturer
  9.4.1 Mexico Prostate Cancer Diagnostics Sales and Market Share by Manufacturer
  9.4.2 Mexico Prostate Cancer Diagnostics Revenue and Market Share by Manufacturer
9.5 Mexico Prostate Cancer Diagnostics Export and Import (2012-2017)

10 PROSTATE CANCER DIAGNOSTICS MARKET FORECAST (2017-2022)

10.1 North America Prostate Cancer Diagnostics Sales, Revenue and Growth Rate (2017-2022)
10.2 Prostate Cancer Diagnostics Market Forecast by Countries (2017-2022)
  10.2.1 United States Prostate Cancer Diagnostics Forecast (2017-2022)
  10.2.2 Canada Prostate Cancer Diagnostics Forecast (2017-2022)
  10.2.3 Mexico Prostate Cancer Diagnostics Forecast (2017-2022)
10.3 Prostate Cancer Diagnostics Market Forecast by Type (2017-2022)
10.4 Prostate Cancer Diagnostics Market Forecast by Application (2017-2022)

11 PROSTATE CANCER DIAGNOSTICS MANUFACTURING COST ANALYSIS

11.1 Prostate Cancer Diagnostics Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Prostate Cancer Diagnostics

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Prostate Cancer Diagnostics Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Prostate Cancer Diagnostics Major Manufacturers in 2016
12.4 Downstream Buyers

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Prostate Cancer Diagnostics Picture
Table Product Specifications of Prostate Cancer Diagnostics
Figure North America Sales Market Share of Prostate Cancer Diagnostics by Types in 2016
Table Types of Prostate Cancer Diagnostics
Figure Tumor Biomarker Tests Picture
Table Major Manufacturers of Tumor Biomarker Tests
Figure Imaging Picture
Table Major Manufacturers of Imaging
Figure Biopsy Picture
Table Major Manufacturers of Biopsy
Figure Other Picture
Table Major Manufacturers of Other
Table North America Prostate Cancer Diagnostics Sales Market Share by Applications in 2016
Table Applications of Prostate Cancer Diagnostics
Figure < 55 Picture
Figure 55-75 Picture
Figure > 75 Picture
Figure United States Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Prostate Cancer Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Table Genomic Health Basic Information, Manufacturing Base and Competitors
Table Genomic Health Prostate Cancer Diagnostics Type and Applications
Table Genomic Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Prostate Cancer Diagnostics Type and Applications
Table Abbott Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table OPKO Basic Information, Manufacturing Base and Competitors
Table OPKO Prostate Cancer Diagnostics Type and Applications
Table OPKO Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table Siemens Healthcare Prostate Cancer Diagnostics Type and Applications
Table Siemens Healthcare Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table DiaSorin Basic Information, Manufacturing Base and Competitors
Table DiaSorin Prostate Cancer Diagnostics Type and Applications
Table DiaSorin Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table bioMeriux Basic Information, Manufacturing Base and Competitors
Table bioMeriux Prostate Cancer Diagnostics Type and Applications
Table bioMeriux Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Prostate Cancer Diagnostics Type and Applications
Table Roche Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table MDx Health Basic Information, Manufacturing Base and Competitors
Table MDx Health Prostate Cancer Diagnostics Type and Applications
Table MDx Health Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table Beckman Coulter Prostate Cancer Diagnostics Type and Applications
Table Beckman Coulter Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Myriad Genetics Basic Information, Manufacturing Base and Competitors
Table Myriad Genetics Prostate Cancer Diagnostics Type and Applications
Table Myriad Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ambry Genetics Basic Information, Manufacturing Base and Competitors
Table Ambry Genetics Prostate Cancer Diagnostics Type and Applications
Table Ambry Genetics Prostate Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Prostate Cancer Diagnostics Sales by Manufacturer (2016-2017)
Figure North America Prostate Cancer Diagnostics Sales Market Share by Manufacturer in 2016
Figure North America Prostate Cancer Diagnostics Sales Market Share by Manufacturer in 2017
Table North America Prostate Cancer Diagnostics Revenue by Manufacturer (2016-2017)
Figure North America Prostate Cancer Diagnostics Revenue Market Share by Manufacturer in 2016
Figure North America Prostate Cancer Diagnostics Revenue Market Share by Manufacturer in 2017
Table North America Prostate Cancer Diagnostics Price by Manufacturers (2016-2017)
Figure Top 3 Prostate Cancer Diagnostics Manufacturer Market Share in 2016
Figure Top 3 Prostate Cancer Diagnostics Manufacturer Market Share in 2017
Figure Top 5 Prostate Cancer Diagnostics Manufacturer Market Share in 2016
Figure Top 5 Prostate Cancer Diagnostics Manufacturer Market Share in 2017
Figure North America Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Table North America Prostate Cancer Diagnostics Sales by Countries (2012-2017)
Table North America Prostate Cancer Diagnostics Sales Market Share by Countries (2012-2017)
Figure North America 2012 Prostate Cancer Diagnostics Sales Market Share by Countries
Figure North America 2016 Prostate Cancer Diagnostics Sales Market Share by Countries
Figure North America Prostate Cancer Diagnostics Revenue and Growth (2012-2017)
Table North America Prostate Cancer Diagnostics Revenue by Countries (2012-2017)
Table North America Prostate Cancer Diagnostics Revenue Market Share by Countries (2012-2017)
Table North America 2012 Prostate Cancer Diagnostics Revenue Market Share by Countries
Table North America 2016 Prostate Cancer Diagnostics Revenue Market Share by Countries
Table North America Prostate Cancer Diagnostics Sales by Type (2012-2017)
Table North America Prostate Cancer Diagnostics Sales Share by Type (2012-2017)
Table North America Prostate Cancer Diagnostics Revenue by Type (2012-2017)
Table North America Prostate Cancer Diagnostics Revenue Share by Type (2012-2017)
Figure North America Tumor Biomarker Tests Sales Growth (2012-2017)
Figure North America Tumor Biomarker Tests Price (2012-2017)
Figure North America Imaging Sales Growth (2012-2017)
Figure North America Imaging Price (2012-2017)
Figure North America Biopsy Sales Growth (2012-2017)
Figure North America Biopsy Price (2012-2017)
Figure North America Other Sales Growth (2012-2017)
Figure North America Other Price (2012-2017)
Table North America Prostate Cancer Diagnostics Sales by Application (2012-2017)
Table North America Prostate Cancer Diagnostics Sales Share by Application (2012-2017)
Figure North America < 55 Sales Growth (2012-2017)
Figure North America 55-75 Sales Growth (2012-2017)
Figure North America > 75 Sales Growth (2012-2017)
Figure United States Prostate Cancer Diagnostics Revenue and Growth (2012-2017)
Figure United States Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Table United States Prostate Cancer Diagnostics Sales by Type (2012-2017)
Table United States Prostate Cancer Diagnostics Sales Market Share by Type (2012-2017)
Table United States Prostate Cancer Diagnostics Sales by Application (2012-2017)
Table United States Prostate Cancer Diagnostics Sales Market Share by Application (2012-2017)
Table United States Prostate Cancer Diagnostics Sales by Manufacturer (2016-2017)
Figure United States Prostate Cancer Diagnostics Sales Market Share by Manufacturer in 2016
Figure United States Prostate Cancer Diagnostics Sales Market Share by Manufacturer in 2017
Table United States Prostate Cancer Diagnostics Revenue by Manufacturer (2016-2017)
Figure United States Prostate Cancer Diagnostics Revenue Market Share by Manufacturer in 2016
Figure United States Prostate Cancer Diagnostics Revenue Market Share by Manufacturer in 2017
Table United States Prostate Cancer Diagnostics Export and Import (2012-2017)
Figure Canada Prostate Cancer Diagnostics Revenue and Growth (2012-2017)
Figure Canada Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Table Canada Prostate Cancer Diagnostics Sales by Type (2012-2017)
Table Canada Prostate Cancer Diagnostics Sales Market Share by Type (2012-2017)
Table Canada Prostate Cancer Diagnostics Sales by Application (2012-2017)
Table Canada Prostate Cancer Diagnostics Sales Market Share by Application (2012-2017)
Table Canada Prostate Cancer Diagnostics Sales by Manufacturer (2016-2017)
Figure Canada Prostate Cancer Diagnostics Sales Market Share by Manufacturer in 2016
Figure Canada Prostate Cancer Diagnostics Sales Market Share by Manufacturer in 2017
Table Canada Prostate Cancer Diagnostics Revenue by Manufacturer (2016-2017)
Figure Canada Prostate Cancer Diagnostics Revenue Market Share by Manufacturer in 2016
Figure Canada Prostate Cancer Diagnostics Revenue Market Share by Manufacturer in 2017
Table Canada Prostate Cancer Diagnostics Export and Import (2012-2017)
Figure Mexico Prostate Cancer Diagnostics Revenue and Growth (2012-2017)
Figure Mexico Prostate Cancer Diagnostics Sales and Growth (2012-2017)
Table Mexico Prostate Cancer Diagnostics Sales by Type (2012-2017)
Table Mexico Prostate Cancer Diagnostics Sales Market Share by Type (2012-2017)
Table Mexico Prostate Cancer Diagnostics Sales by Application (2012-2017)
Table Mexico Prostate Cancer Diagnostics Sales Market Share by Application (2012-2017)
Table Mexico Prostate Cancer Diagnostics Sales by Manufacturer (2016-2017)
Figure Mexico Prostate Cancer Diagnostics Sales Market Share by Manufacturer in 2016
Figure Mexico Prostate Cancer Diagnostics Sales Market Share by Manufacturer in 2017
Table Mexico Prostate Cancer Diagnostics Revenue by Manufacturer (2016-2017)
Figure Mexico Prostate Cancer Diagnostics Revenue Market Share by Manufacturer in 2016
Figure Mexico Prostate Cancer Diagnostics Revenue Market Share by Manufacturer in 2017
Table Mexico Prostate Cancer Diagnostics Export and Import (2012-2017)
Figure North America Prostate Cancer Diagnostics Sales, Revenue and Growth Rate (2017-2022)
Table North America Prostate Cancer Diagnostics Sales Forecast by Countries (2017-2022)
Table North America Prostate Cancer Diagnostics Market Share Forecast by Countries (2017-2022)
Figure United States Prostate Cancer Diagnostics Sales Forecast (2017-2022)
Figure Canada Prostate Cancer Diagnostics Sales Forecast (2017-2022)
Figure Mexico Prostate Cancer Diagnostics Sales Forecast (2017-2022)
Table North America Prostate Cancer Diagnostics Sales Forecast by Type (2017-2022)
Table North America Prostate Cancer Diagnostics Market Share Forecast by Type (2017-2022)
Table North America Prostate Cancer Diagnostics Sales Forecast by Application (2017-2022)
Table North America Prostate Cancer Diagnostics Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer Diagnostics
Figure Manufacturing Process Analysis of Prostate Cancer Diagnostics
Figure Prostate Cancer Diagnostics Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Diagnostics Major Manufacturers in 2016
Table Major Buyers of Prostate Cancer Diagnostics
Table Distributors/Traders/ Dealers List